MDK.P — MDK Acquisition Income Statement
0.000.00%
- CA$0.31m
- CA$0.20m
Annual income statement for MDK Acquisition, fiscal year end - November 30th, CAD millions except per share, conversion factor applied.
2022 November 30th | 2023 November 30th | 2024 November 30th | 2025 November 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.036 | 0.121 | 0.057 | 0.079 |
| Operating Profit | -0.036 | -0.121 | -0.057 | -0.079 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -0.036 | -0.121 | -0.053 | -0.076 |
| Net Income After Taxes | -0.036 | -0.121 | -0.053 | -0.076 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.036 | -0.121 | -0.053 | -0.076 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.036 | -0.121 | -0.053 | -0.076 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.006 | -0.019 | -0.009 | -0.012 |
| Dividends per Share |